MASSDEVICE ON CALL — Following the U.S. House of Representatives’ sweeping repeal of the impending 2.3% medical device tax, lobbying efforts have turned to urging the Dem-led Senate to follow suit.
As a Senate bill repealing the medical device tax languishes without Democratic support, some have speculated that repeal efforts are dead in the water, but AdvaMed president & CEO Stephen Ubl took to the opinion pages to urge the nation’s upper house to spike the levy.
"One of the best things Congress could do for the economy this year would be to pass this legislation and repeal the device tax," Ubl wrote in an op-ed for the Telegram & Gazette.
"Given the value of the industry’s products and the growth of its workforce, legislators should be supporting and cultivating these companies – not smothering them," Ubl added. "But that’s precisely what the device tax does."
Prosthetics need a hand
Researchers warn that prosthetic hand development hasn’t progressed much in more than 2 decades, based on a study of the force required to operate several modern-day devices compared to their predecessors. One comparison found that a hand developed in 1945 performed better in grip tests than newer devices.
Read more
The Abdominal Aortic Tourniquet makes it way onto the battlefield
The U.S. Special Operations Command took possession of its 1st shipment of Abdominal Aortic Tourniquets, an inflatable device that straps around the belly, pushing in a balloon that clamps the abdominal aorta against the spine to cut off blood flow that would result in death is allowed to go unchecked.
Read more
Wireless dental sensor monitors oral bacteria
A wireless sensor designed to adhere to a tooth can monitor breathing and saliva, transmitting data wirelessly that could help monitor oral bacteria and provide an early warning for potential health complications.
Read more
In-Health survey details industry’s most important regulatory factors
Among chief concerns of the the FDA’s regulatory process, predictability topped the list, followed by regulatory requirements, guidance documents, agency interaction and international experience, according to the largest-ever industry-wide survey yet conducted about the FDA.
Read more
